Pineda-Muyir, Claudia

Pineda-Muyir, Claudia was paid $355K by Medicaid between Nov 2021 and Dec 2024, across 54 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 58% of everything it billed.

33Billing provider infoPINEDA-MUYIR, CLAUDIA
BROOKLYN, NY 11220

33aNPI1114166980assigned 02/18/2009

33bProvider typePhysician Assistant

28Total paid$355K

24GClaims36,804

24DCodes billed54

24AFirst – last monthNov 2021 – Dec 2024

Compared with peers

Next to other Physician Assistant providers in New York

Rank by total paid#16 of 263

Median peer was paid$3K

This provider vs. median109×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	389	$6K
2022	11,205	$103K
2023	9,024	$83K
2024incomplete	16,186	$164K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	58%	3,253	2,737	$205K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	7.2%	677	638	$26K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	5.4%	240	236	$19K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	4.2%	172	171	$15K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	3.3%	427	388	$12K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	3.1%	871	791	$11K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	2.4%	178	172	$9K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	2.2%	87	87	$8K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	2.2%	411	375	$8K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	1.4%	69	68	$5K
99484		1.1%	192	192	$4K
94060		1.1%	120	117	$4K

42 more codes

90686		1.1%	201	$4K
93000		1.0%	322	$4K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	1.0%	44	$4K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	188	$3K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	176	$3K
94760		<1%	3,719	$2K
G0444	Annual depression screening, 5 to 15 minutes	<1%	195	$2K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	61	$2K
G0447	Face-to-face behavioral counseling for obesity, 15 minutes	<1%	167	$1K
3074F		<1%	3,956	$1K
36415	Collection of venous blood by venipuncture	<1%	1,475	$999.27
3078F		<1%	3,949	$937.82
97802		<1%	180	$735.43
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	79	$613.80
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	210	$572.53
94664		<1%	121	$539.45
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	69	$354.32
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	312	$344.77
99497		<1%	12	$276.67
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	29	$246.56
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	138	$137.22
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	312	$117.82
99072		<1%	2,421	$100.00
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	185	$88.14
J7050	Infusion, normal saline solution, 250 cc	<1%	216	$78.15
3044F		<1%	508	$40.00
G0445	High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes	<1%	16	$27.82
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	61	$18.80
3008F		<1%	3,694	$0.01
2001F		<1%	3,656	$0.01
99000		0%	1,627	$0.00
3061F		0%	354	$0.00
3048F		0%	304	$0.00
94010		0%	117	$0.00
3049F		0%	64	$0.00
S9451	Exercise classes, non-physician provider, per session	0%	137	$0.00
3050F		0%	13	$0.00
4013F		0%	115	$0.00
1160F		0%	410	$0.00
4274F		0%	210	$0.00
G8483	Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)	0%	63	$0.00
3077F		0%	21	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.